Epidemiological cut‐off values for itraconazole and ravuconazole for <i>Madurella mycetomatis</i> , the most common causative agent of mycetoma-Reference-Cited by-同舟云学术

Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis , the most common causative agent of mycetoma

Published:2022-08-25 Issue:12 Volume:65 Page:1170-1178
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Nyuykonge Bertrand¹^ORCID,Siddig Emmanuel E.²,Mhmoud Najwa Adam²,Nyaoke Borna A.³^ORCID,Zijlstra Eduard E.⁴,Verbon Annelies¹,Bakhiet Sahar²,Fahal Ahmed H.²,van de Sande Wendy W. J.¹

Affiliation:

1. Department of Medical Microbiology and Infectious Diseases Erasmus MC, University Medical Centre Rotterdam Rotterdam the Netherlands

2. Mycetoma Research Centre University of Khartoum Khartoum Sudan

3. Drugs for Neglected Diseases initiative (DNDi) Nairobi Kenya

4. Drugs for Neglected Diseases initiative (DNDi) Geneva Switzerland

Funder

Drugs for Neglected Diseases initiative

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13509

Reference37 articles.

1. Mycetoma: a unique neglected tropical disease

2. A Madurella mycetomatis Grain Model in Galleria mellonella Larvae

3. Closing the mycetoma knowledge gap

4. Drug therapy for mycetoma;Scolding PS;Chochrane Database Syst Rev,2018

5. Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial;The Lancet Infectious Diseases;2024-08

2. An updated list of eumycetoma causative agents and their differences in grain formation and treatment response;Clinical Microbiology Reviews;2024-06-13

3. Novel Compound MMV1804559 from the Global Health Priority Box Exhibits In Vitro and In Vivo Activity against Madurella mycetomatis;International Journal of Molecular Sciences;2024-06-05

4. Naphthylisoquinoline alkaloids: novel agents against the causative pathogens of eumycetoma and actinomycetoma— en route to broad-spectrum antimycetomal drugs;Antimicrobial Agents and Chemotherapy;2024-05-02

5. A Novel Report of mycetoma with Spinal Spread due to Madurella fahalli from India;Indian Journal of Medical Microbiology;2024-03